Neurologic Outcomes After Radiation Therapy for Severe Spinal Cord Compression in Multiple Myeloma
Journal of Bone and Joint Surgery · 16.08.2023 · 105 (16) · 1261-1269
DOI: 10.2106/jbjs.22.01335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Joint Surgery, online erschienen am 01.06.2023. Verfasst von H Zijlstra und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Orthopaedic Oncology Service, Massachusetts General Hospital-Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Spinal Cord Compression, Multiple Myeloma, Spinal Neoplasms, Spinal Injuries. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Bone destruction is the most frequent disease-defining clinical feature of multiple myeloma (MM), resulting in skeletal-related events such as back pain, pathological fractures, or neurologic compromise including epidural spinal cord compression (ESCC). Up to 24% of patients with MM will be affected by ESCC. Radiation therapy has been proven to be highly effective in pain relief in patients with MM. However, a critical knowledge gap remains with regard to neurologic outcomes in patients with high-grade ESCC treated with radiation.
Methods
We retrospectively included 162 patients with MM and high-grade ESCC (grade 2 or 3) who underwent radiation therapy of the spine between January 2010 and July 2021. The primary outcome was the American Spinal Injury Association (ASIA) score after 12 to 24 months, or the last known ASIA score if the patient had had a repeat treatment or died. Multivariable logistic regression was used to assess factors associated with poor neurologic outcomes after radiation, defined as neurologic deterioration or lack of improvement.
Results
After radiation therapy, 34 patients (21%) had no improvement in their impaired neurologic function and 27 (17%) deteriorated neurologically. Thirty-six patients (22%) underwent either surgery or repeat irradiation after the initial radiation therapy. There were 100 patients who were neurologically intact at baseline (ASIA score of E), of whom 16 (16%) had neurologic deterioration. Four variables were independently associated with poor neurologic outcomes: baseline ASIA (odds ratio [OR] = 6.50; 95% confidence interval [CI] = 2.70 to 17.38; p < 0.001), Eastern Cooperative Oncology Group (ECOG) performance status (OR = 6.19; 95% CI = 1.49 to 29.49; p = 0.015), number of levels affected by ESCC (OR = 4.02; 95% CI = 1.19 to 14.18; p = 0.026), and receiving steroids prior to radiation (OR = 4.42; 95% CI = 1.41 to 16.10; p = 0.015).
Conclusions
Our study showed that 38% of patients deteriorated or did not improve neurologically after radiation therapy for high-grade ESCC. The results highlight the need for multidisciplinary input and efforts in the treatment of high-grade ESCC in patients with MM. Future studies will help to improve patient selection for specific and standardized treatments and to clearly delineate which patients are likely to benefit from radiation therapy. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Orthopaedic Oncology Service, Massachusetts General Hospital-Harvard Medical School, Boston, Massachusetts.
- Department of Orthopedic Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
- Department of Hematology/Oncology-Center for Multiple Myeloma, Massachusetts General Hospital-Harvard Medical School, Boston, Massachusetts.
- Department of Radiation Oncology, Massachusetts General Hospital-Harvard Medical School, Boston, Massachusetts.
- Department of Orthopedic Surgery, St. Antonius Hospital, Utrecht, The Netherlands.
- Department of Orthopedic Surgery, OLVG, Amsterdam, Amsterdam, The Netherlands.
ORCID-Profile: H Zijlstra, B M Striano, A M Crawford, O Q Groot, N Raje, D G Tobert, C G Patel, N Wolterbeek, D Delawi, D H R Kempen, J J Verlaan, J H Schwab
Zitieren
APA
Zijlstra, H., Striano, B. M., Crawford, A. M., Groot, O. Q., Raje, N., Tobert, D. G., Patel, C. G., Wolterbeek, N., Delawi, D., Kempen, D. H. R., Verlaan, J. J., & Schwab, J. H. (2023). Neurologic Outcomes After Radiation Therapy for Severe Spinal Cord Compression in Multiple Myeloma. Journal of Bone and Joint Surgery, 105(16), 1261-1269. https://doi.org/10.2106/jbjs.22.01335
Vancouver
Zijlstra H, Striano BM, Crawford AM, Groot OQ, Raje N, Tobert DG, et al. Neurologic Outcomes After Radiation Therapy for Severe Spinal Cord Compression in Multiple Myeloma. Journal of Bone and Joint Surgery. 2023;105(16):1261-1269. doi:10.2106/jbjs.22.01335
BibTeX
@article{Zijlstra2023,
author = {Zijlstra, H and Striano, B M and Crawford, A M and Groot, O Q and Raje, N and Tobert, D G and Patel, C G and Wolterbeek, N and Delawi, D and Kempen, D H R and Verlaan, J J and Schwab, J H},
title = {Neurologic Outcomes After Radiation Therapy for Severe Spinal Cord Compression in Multiple Myeloma},
journal = {Journal of Bone and Joint Surgery},
year = {2023},
volume = {105},
number = {16},
pages = {1261--1269},
doi = {10.2106/jbjs.22.01335}
}
EUVIMED